Neurvati
Business Services · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.neurvati.comRevenue
$5.3 MillionIndustry
About Neurvati
Neurvati Org Chart
Is Neurvati your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Neurvati
Check out if Neurvati is spiking on competitors!
Earning: See what the market has to say on Neurvati recently announced quarterly report
Click to see if Neurvati had a recent Job posting/layoffs
Neurvati, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Neurvati has new funding data
Product Launch: Get notified when Neurvati launches new products
Check if Neurvati has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Neurvati
Find more new buyers
Compare Similar Companies to Neurvati
Compare insights from companies similar to Neurvati, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Neurvati is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Neurvati is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Neurvati.
Neurvati Tech Stack
A closer look at the technologies used by Neurvati
Most Recent Scoops
Neurvati News & Media
Neurvati Neurosciences Appoints Carlos Martin as Chief Commercial Officer
NEW YORK, Nov. 13, 2025 /PRNewswire/ -- Neurvati Neurosciences, the neuroscience development platform of Blackstone Life Sciences, today announced the appointment of Carlos Martin as Chief Commercial Officer (CCO). Martin brings more than 20 years of leadership experience across global...GRIN Therapeutics Presents Multiple Clinical Development Updates for Radiprodil at 2025 ILAE International Epilepsy Congress
Poster presentations included overviews of plans and designs for the global Phase 3 Beeline trial of investigational radiprodil in GRIN-related neurodevelopmental disorder (GRIN-NDD) and Phase 1b/2a Astroscape trial in tuberous sclerosis complex and focal cortical dysplasia type II...Neurvati Neurosciences and GRIN Therapeutics Announce Appointment of Gail Farfel, PhD to Their Boards of Directors
NEW YORK, June 18, 2025 /PRNewswire/ -- Neurvati Neurosciences, a clinical-stage biotechnology company dedicated to bringing a new generation of therapies to people affected by neurological and psychiatric disorders, and GRIN Therapeutics, Inc., a leader in the development of therapies to...GRIN Therapeutics and Angelini Pharma Enter into Exclusive Collaboration to Develop and Commercialize Radiprodil Outside North America
GRIN also announces closing of $140 million Series D financing, including a $65 million strategic equity investment from Angelini Pharma and $75 million from existing investor Blackstone Life Sciences Collaboration combines Angelini Pharma's global reach and focus on complex neurological...
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neurvati
Neurvati is a collaborative platform focused on advancing drug development for neurological and psychiatric disorders, with the aim of improving health and access to treatment for patients globally. Utilizing a search-evaluate-invest-develop strategy, Neurvati aims to discover and develop novel therapies while engaging with strategic partners and p... Read More